A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer
I4D-EW-JTJG - ClinicalTrials.gov - NCT02778126
The main purpose of this study is to evaluate the safety of the study drug known as LY2606368 in participants with advanced cancer or cancer that has spread to other parts of the body.
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Advanced CancerWhat the trial is testing?
PrexasertibCould I receive a Placebo?
NoEnrollment Goal
6Trial Dates
Sep 22, 2016 - Jul 27, 2017How long will I be in the trial?
Your participation could last up to 5 weeks depending on how you and your tumor respond.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo